Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin/Ezetimibe vs Rosuvastatin in LVDD and Hyperlipidemia
NCT04433533Phase 4Unknown
- Sponsor
- Yonsei University
- Start
- Jan 2021
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ezetimibe in hyperlipidemia, left ventricular diastolic dysfunction (LVDD), sponsored by Yonsei University. Status: unknown.
02
Drugs
ezetimibe
03
Conditions
hyperlipidemialeft ventricular diastolic dysfunction (LVDD)
Beyond the preview
Go deeper on NCT04433533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04433533.